Watermelon stomach is a source of recurrent gastrointestinal hemorrhage and anemia.
In this study, doctors from the United States described the endoscopic appearance and treatment outcomes in watermelon stomach patients with and without portal hypertension.
The team identified all patients with watermelon stomach enrolled in a hemostasis research group’s prospective study between 1991 to 1999. They collected data using standardized forms.
Comparisons were made using the chi-squared test, Wilcoxon rank-sum test, and Wilcoxon signed-rank test.
|Patients with portal hypertension had diffuse antral angiomas.|
The doctors found that in 4% of 744 patients with nonvariceal upper gastrointestinal hemorrhage watermelon stomach was the cause of bleeding. They also found that 8 of these patients also had portal hypertension.
Patients with portal hypertension had diffuse antral angiomas, compared to the classic linear arrays in those without portal hypertension.
The team determined that palliative endoscopic treatment was associated with a rise in hematocrit and a decrease in blood transfusion or hospitalization in patients with and without portal hypertension.
Dr Dulai's team concluded, "Watermelon stomach patients with and without portal hypertension had similar clinical presentations".
"The endoscopic findings differed in that those with portal hypertension had more diffuse gastric angiomas".
"Bleeding was effectively palliated by endoscopic treatment, regardless of the presence of portal hypertension".